Evidence map›Paper›PMID 32046786›Full record

SynthesisAntimicrobial resistance and infection control2020

Risk factors for fecal carriage of drug-resistant Escherichia coli: a systematic review and meta-analysis.

Yuan Hu, Yusuke Matsui, Lee W Riley

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Antimicrobial resistance and infection control, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. One Health Determinants ofInternational journal of molecular sciences · 2023
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Gut residentmedRxiv : the preprint server for health sciences · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Advocacy for Responsible Antibiotic Production and Use.Antibiotics (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Article
  13. High levels of gut carriage of antimicrobial-resistant Escherichia coli in community settings in Rio de Janeiro, Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Article
  14. Use of Molecular Methods To DetectJournal of clinical microbiology · 2022
    Article
  15. Antimicrobial Resistance and Human Mobility.Infection and drug resistance · 2022
    Review
  16. Article
  17. High Prevalence ofFrontiers in microbiology · 2022
    Article
  18. Molecular epidemiology of extended-spectrum beta-lactamase-producing extra-intestinal pathogenic Escherichia coli strains over a 2-year period (2017-2019) from Zimbabwe.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yuan HuSchool of Public Health, Division of Epidemiology, University of California Berkeley, 530E Li Ka Shing, Berkeley, 94720, CA, USA. yuan_hu@berkeley.edu.ORCID 0000-0002-3031-9341
Yusuke MatsuiSchool of Public Health, Division of Infectious Disease and Vaccinology, University of California Berkeley, 530E Li Ka Shing, Berkeley, 94720, CA, USA.
Lee W RileySchool of Public Health, Division of Infectious Disease and Vaccinology, University of California Berkeley, 530E Li Ka Shing, Berkeley, 94720, CA, USA.
University of California, Berkeley · USBerkeley Public Health Division · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntimicrobial resistance is a serious public health problem. Fecal carriage of drug-resistant bacteria has been suggested as an important source of antimicrobial resistant genes (ARGs). We aimed to identify risk factors associated with fecal carriage of drug-resistant commensal Escherichia coli among healthy adult population.

methodsWe conducted a systematic review and meta-analysis following the PRISMA guideline. We identified observational studies published from 2014 to 2019 through PubMed, Embase, and Web of Science. Studies were eligible if they investigated and reported risk factors and accompanying measure of associations for fecal carriage of drug-resistant E. coli for healthy population aged 18-65. Data on risk factors assessed in three or more studies were extracted.

resultsFifteen of 395 studies involving 11480 healthy individuals were included. The pooled prevalence of drug-resistant Enterobacteriaceae was 14% (95% confidence interval [CI] 8-23%). Antimicrobial use within the 12 months prior to stool culture (odds ratio [OR] 1.84 [95%CI 1.35-2.51]), diarrhea symptoms (OR 1.56 [95%CI 1.09-2.25]), travel to India (OR 4.15 [95%CI 2.54-6.78]), and vegetarian diet (OR 1.60 [95%CI 1.00(1.0043)-2.56(2.5587)]) were associated with increased risk of fecal carriage of drug-resistant E. coli. Among travellers, antimicrobial use (OR 2.81 [95%CI 1.47-5.36]), diarrhea symptoms (OR 1.65 [95%CI 1.02-2.68]), travel to India (OR 3.80 [95%CI 2.23-6.47]), and vegetarian diet (OR 1.92 [95%CI 1.13-3.26]) were associated with increased risk. Among general adult population, antimicrobial use (OR 1.51 [95%CI 1.17-1.94]), diarrhea symptoms (OR 1.53 [95%CI 1.27-1.84]), and travel to Southeast Asia (OR 1.67 [95%CI 1.02-2.73]) were associated with the increased risk of drug-resistant E. coli carriage.

conclusionsThe findings indicate that dietary habit as well as past antimicrobial use and travel to high-risk country are associated with the risk of fecal carriage of drug-resistant commensal E. coli.

Indexed as

Drug Resistance, BacterialEscherichia coliRisk FactorsAdolescentAdultAgedAnti-Bacterial AgentsCarbapenem-Resistant EnterobacteriaceaeEscherichia coli InfectionsFecesFeeding BehaviorGenes, BacterialHumansMiddle AgedPrevalenceTravelAnti-Bacterial AgentsCommensal Escherichia coliDrug resistanceMeta-analysisRisk factorsSystematic review

Identifiers

PMID32046786
PMCPMC7014593
OpenAlexW3007136180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.